Paroxysmal AV Block Etiology: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
 
Line 6: Line 6:
*'''[[Intrinsic conduction]]/ [[structural]] defects particularly those located in this intra [[His Bundle]] ([[intrinsic paroxysmal AV block]]), low adenosine levels ([[Intrinsic paroxysmal AV block|idiopathic paroxysmal AV block]]) and increase vagal tone/vagal surge ([[Extrinsic paroxysmal av block|extrinsic paroxysmal AV block]]) are the major causes of [[paroxysmal AV block]]'''.
*'''[[Intrinsic conduction]]/ [[structural]] defects particularly those located in this intra [[His Bundle]] ([[intrinsic paroxysmal AV block]]), low adenosine levels ([[Intrinsic paroxysmal AV block|idiopathic paroxysmal AV block]]) and increase vagal tone/vagal surge ([[Extrinsic paroxysmal av block|extrinsic paroxysmal AV block]]) are the major causes of [[paroxysmal AV block]]'''.
*However, some studies have shown an association of [[AV nodal block|AV nodal]] blocking agents ([[beta blockers]], [[calcium channel blockers]]),  [[Degenerative disease|degenerative]] [[valvular heart disease]], [[Degeneration (medical)|degeneration]] of the [[Conduction system disease|conduction system]] (the [[Bundle of His|His bundle]] in particular), [[acute coronary syndromes]] ([[inferior]] [[Anterior|/anterior]] wall myocardial infarction in particular) and [[paroxysmal AV block]].
*However, some studies have shown an association of [[AV nodal block|AV nodal]] blocking agents ([[beta blockers]], [[calcium channel blockers]]),  [[Degenerative disease|degenerative]] [[valvular heart disease]], [[Degeneration (medical)|degeneration]] of the [[Conduction system disease|conduction system]] (the [[Bundle of His|His bundle]] in particular), [[acute coronary syndromes]] ([[inferior]] [[Anterior|/anterior]] wall myocardial infarction in particular) and [[paroxysmal AV block]].
*Less common causes that have been cited are [[Lev- Lenegre]] disease, [[Aneurysmal disease|aneurysmal]] membranous [[septum]], [[rheumatic heart disease]], [[Mitral valve|mitral]] valvulitis, [[sarcoidosis]], h/o [[surgery]] and [[infective endocarditis]] with [[abscess]] formation.  
*Less common causes that have been cited are [[Lev- Lenegre]] disease, [[Aneurysmal disease|aneurysmal]] membranous [[septum]], [[rheumatic heart disease]], [[Mitral valve|mitral]] valvulitis, [[sarcoidosis]], h/o [[surgery]] and [[infective endocarditis]] with [[abscess]] formation.<ref name="pmid28496928">{{cite journal| author=Guerrero-Márquez FJ, Arana-Rueda E, Pedrote A| title=Idiopathic Paroxysmal Atrio-Ventricular Block. What is The Mechanism? | journal=J Atr Fibrillation | year= 2016 | volume= 9 | issue= 3 | pages= 1449 | pmid=28496928 | doi=10.4022/jafib.1449 | pmc=5368548 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=28496928  }} </ref>
*A study of 20 patients conducted by '''Zabarski et al''' found that [[ischemic heart disease]], [[dilated cardiomyopathy]], [[carotid sinus hypersensitivity]], chronic AV blocker consumption and [[aortic valve]] replacement were associated [[paroxysmal AV block]].
*A study of 20 patients conducted by '''Zabarski et al''' found that [[ischemic heart disease]], [[dilated cardiomyopathy]], [[carotid sinus hypersensitivity]], chronic AV blocker consumption and [[aortic valve]] replacement were associated [[paroxysmal AV block]].<ref name="pmid15561325">{{cite journal| author=Shohat-Zabarski R, Iakobishvili Z, Kusniec J, Mazur A, Strasberg B| title=Paroxysmal atrioventricular block: clinical experience with 20 patients. | journal=Int J Cardiol | year= 2004 | volume= 97 | issue= 3 | pages= 399-405 | pmid=15561325 | doi=10.1016/j.ijcard.2003.10.023 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=15561325  }} </ref>


==2018 ACC/AHA/HRS Guideline on the Evaluation and Management of Patients With Bradycardia and Cardiac Conduction Delay: Etiology of AV Block==
==2018 ACC/AHA/HRS Guideline on the Evaluation and Management of Patients With Bradycardia and Cardiac Conduction Delay: Etiology of AV Block==


[[Image:Etiology of AV Block.JPG|thumb|center|500px| Etiology of AV Block]]
[[Image:Etiology of AV Block.JPG|thumb|center|500px| Etiology of AV Block<ref name="pmid30412710">{{cite journal| author=Kusumoto FM, Schoenfeld MH, Barrett C, Edgerton JR, Ellenbogen KA, Gold MR | display-authors=etal| title=2018 ACC/AHA/HRS Guideline on the Evaluation and Management of Patients With Bradycardia and Cardiac Conduction Delay: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines, and the Heart Rhythm Society. | journal=J Am Coll Cardiol | year= 2019 | volume= 74 | issue= 7 | pages= 932-987 | pmid=30412710 | doi=10.1016/j.jacc.2018.10.043 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=30412710  }} </ref>]]


==References==
==References==
<references />

Latest revision as of 09:06, 26 June 2020

Overview

Intrinsic conduction/ structural defects particularly those located in this intra His Bundle (intrinsic paroxysmal AV block), low adenosine levels (idiopathic paroxysmal AV block) and increase vagal tone/vagal surge (extrinsic vagal paroxysmal AV block) are the major causes of paroxysmal AV block. However, several reversible causes need to be ruled out before coming to a diagnosis.

Etiology

2018 ACC/AHA/HRS Guideline on the Evaluation and Management of Patients With Bradycardia and Cardiac Conduction Delay: Etiology of AV Block

Etiology of AV Block[3]

References

  1. Guerrero-Márquez FJ, Arana-Rueda E, Pedrote A (2016). "Idiopathic Paroxysmal Atrio-Ventricular Block. What is The Mechanism?". J Atr Fibrillation. 9 (3): 1449. doi:10.4022/jafib.1449. PMC 5368548. PMID 28496928.
  2. Shohat-Zabarski R, Iakobishvili Z, Kusniec J, Mazur A, Strasberg B (2004). "Paroxysmal atrioventricular block: clinical experience with 20 patients". Int J Cardiol. 97 (3): 399–405. doi:10.1016/j.ijcard.2003.10.023. PMID 15561325.
  3. Kusumoto FM, Schoenfeld MH, Barrett C, Edgerton JR, Ellenbogen KA, Gold MR; et al. (2019). "2018 ACC/AHA/HRS Guideline on the Evaluation and Management of Patients With Bradycardia and Cardiac Conduction Delay: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines, and the Heart Rhythm Society". J Am Coll Cardiol. 74 (7): 932–987. doi:10.1016/j.jacc.2018.10.043. PMID 30412710.